The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Treatment of Clostridium difficile Infection
Abstract
Recent outbreaks of Clostridium difficile infection (CDI) in North America have been due to a more virulent, possibly more resistant strain that causes more-severe disease, making prompt recognition of cases and optimal management of infection essential for a successful therapeutic outcome. Treatment algorithms are presented to help guide the management of patients with CDI. Metronidazole has been recommended as initial therapy since the late 1990s and continues to be the first choice for all but seriously ill patients and those with complicated or fulminant infections or multiple recurrences of CDI, for whom vancomycin is recommended. Other options for recurrent CDI, such as probiotics and currently available anion-exchange resins, have limited efficacy and are potentially harmful. Intravenous immunoglobulin may benefit patients with refractory, recurrent, or severe disease, but no controlled data are available. Two antimicrobials available in the United States for other indications, nitazoxanide and rifaximin, have been used successfully for CDI treatment but, like metronidazole, lack United States Food and Drug Administration approval for this indication. Experimental treatments currently in clinical development include a toxin-binding polymer, tolevamer; 2 poorly absorbed antimicrobials, OPT-80 (formerly known as Difimicin) and ramoplanin; monoclonal antibodies; and a C. difficile vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Self-citationLoo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
McFarland, L. V. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510480037031 · Cited by 857
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
Self-citationBreaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis
D'Souza, A. L., Rajkumar, C., Cooke, J., & Bulpitt, C. J. (2002) · BMJ · doi:10.1136/bmj.324.7350.1361 · Cited by 664
Clostridium Difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/648363 · Cited by 631
Self-citationFulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications
Dallal, R. M., Harbrecht, B. G., Boujoukas, A. J., Sirio, C. A., Farkas, L. M., Lee, K. K., & Simmons, R. L. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00008 · Cited by 628
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
Self-citationPepin, J. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050978 · Cited by 606
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., Garcia, R. J., Brandmarker, S., Bowen, K., Borjal, D., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/318130 · Cited by 529
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Musher, D. M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., & Hamill, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/430311 · Cited by 504
BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., & Jarvinen, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380455 · Cited by 426
Clostridium difficile-associated diarrhea in adults
Poutanen, S. M. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031189 · Cited by 410
Clostridium difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30141083 · Cited by 398
Self-citationInvasive Saccharomyces Infection: A Comprehensive Review
Enache-Angoulvant, A., & Hennequin, C. (2005) · Clinical Infectious Diseases · doi:10.1086/497832 · Cited by 369
Antibiotic treatment for Clostridium difficile -associated diarrhoea in adults
Nelson, R. L., Suda, K. J., & Evans, C. T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004610.pub5 · Cited by 366
Lamontagne, F., Labb??, A.-C., Haeck, O., Lesur, O., Lalancette, M., Patino, C., Leblanc, M., Laverdi??re, M., & P??pin, J. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000236628.79550.e5 · Cited by 359
Epidemiology of Recurrences or Reinfections of Clostridium difficile -Associated Diarrhea
Barbut, F., Richard, A., Hamadi, K., Chomette, V., Burghoffer, B., & Petit, J.-C. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.6.2386-2388.2000 · Cited by 355
Diagnosis and Treatment of Clostridium difficile Colitis
Fekety, R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500010081036 · Cited by 354
Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics
McFarland, L. V., Surawicz, C. M., Rubin, M., Fekety, R., Elmer, G. W., & Greenberg, R. N. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501553 · Cited by 353
Olson, M. M., Shanholtzer, C. J., Lee, J. T., & Gerding, D. N. (1994) · Infection Control & Hospital Epidemiology · doi:10.1086/646934 · Cited by 339
Self-citationBolton, R. P., & Culshaw, M. A. (1986) · Gut · doi:10.1136/gut.27.10.1169 · Cited by 320
Johnson, S., Schriever, C., Galang, M., Kelly, C. P., & Gerding, D. N. (2007) · Clinical Infectious Diseases · doi:10.1086/511870 · Cited by 312
Self-citationFekety, R., Silva, J., Kauffman, C., Buggy, B., & Gunner Deery, H. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90223-4 · Cited by 293
Leung, D. Y. M., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T., & Flores, A. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83393-1 · Cited by 278
Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea
Sougioultzis, S., Kyne, L., Drudy, D., Keates, S., Maroo, S., Pothoulakis, C., Giannasca, P. J., Lee, C. K., Warny, M., Monath, T. P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.004 · Cited by 260
Gaynes, R., Rimland, D., Killum, E., Ken Lowery, H., Johnson II, T. M., Killgore, G., & Tenover, F. C. (2004) · Clinical Infectious Diseases · doi:10.1086/381551 · Cited by 251
Nitazoxanide for the Treatment of Clostridium difficile Colitis
Musher, D. M., Logan, N., Hamill, R. J., DuPont, H. L., Lentnek, A., Gupta, A., & Rossignol, J.-F. (2006) · Clinical Infectious Diseases · doi:10.1086/506351 · Cited by 249
Pepin, J., Routhier, S., Gagnon, S., & Brazeau, I. (2006) · Clinical Infectious Diseases · doi:10.1086/501126 · Cited by 246
Clostridium difficile-associated disease: new challenges from an established pathogen.
Sunenshine, R. H., & McDonald, L. C. (2006) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.73.2.187 · Cited by 242
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients
Lherm, T., Monet, C., Nougière, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., & Malbrunot, C. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1267-9 · Cited by 238
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
Tedesco, F. J., Gordon, D., & Fortson, W. C. (1985) · PubMed · Cited by 217
Cassone, M., Serra, P., Mondello, F., Girolamo, A., Scafetti, S., Pistella, E., & Venditti, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5340-5343.2003 · Cited by 215
Curry, S. R., Marsh, J. W., Muto, C. A., O'Leary, M. M., Pasculle, A. W., & Harrison, L. H. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01599-06 · Cited by 204
Self-citationLouie, T. J., Peppe, J., Watt, C. K., Johnson, D., Mohammed, R., Dow, G., Weiss, K., Simon, S., John, J. F., Garber, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/506349 · Cited by 203
Dendukuri, N. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050350 · Cited by 203
McPherson, S., Rees, C. J., Ellis, R., Soo, S., & Panter, S. J. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0511-8 · Cited by 201
Relapsing Clostridium difficile Enterocolitis Cured by Rectal Infusion of Normal Faeces
Schwan, A., Sjolin, S., Trottestam, U., & Aronsson, B. (1984) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548409087145 · Cited by 201
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh176 · Cited by 200
Hubert, B., Loo, V. G., Bourgault, A.-M., Poirier, L., Dascal, A., Fortin, E., Dionne, M., & Lorange, M. (2007) · Clinical Infectious Diseases · doi:10.1086/510391 · Cited by 196
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
Surawicz, C. M., McFarland, L. V., Elmer, G., & Chinn, J. (1989) · PubMed · Cited by 179
Persky, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02095-5 · Cited by 179
Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.
Bowden, T. A., Ar, M., & Le, L. (1981) · PubMed · Cited by 179
Alternative treatments for Clostridium difficile disease: what really works?
McFarland, L. V. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45753-0 · Cited by 178
Young, G. P., Ward, P. B., Bayley, N., Gordon, D., Higgins, G., Trapani, J. A., McDonald, M. I., Labrooy, J., & Hecker, R. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90206-9 · Cited by 171
McFarland, L. V. (1994) · JAMA · doi:10.1001/jama.271.24.1913 · Cited by 166
Kink, J. A., & Williams, J. A. (1998) · Infection and Immunity · doi:10.1128/iai.66.5.2018-2025.1998 · Cited by 159
Clostridium difficileInfection in Patients with Neutropenia
Gorschlüter, M., Glasmacher, A. G., Hahn, C., Schakowski, F., Ziske, C. G., Molitor, E., Marklein, G., Sauerbruch, T., & Schmidt‐Wolf, I. G. H. (2001) · Clinical Infectious Diseases · doi:10.1086/322616 · Cited by 157
Kotloff, K. L., Wasserman, S. S., Losonsky, G. A., Thomas, W. D., Nichols, R., Edelman, R., Bridwell, M. W., & Monath, T. P. C. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.988-995.2001 · Cited by 156
Treatment of relapsingClostridium difficile diarrhoea by administration of a non-toxigenic strain
SEAL, D. V., Borriello, S. P., Barclay, F. E., Welch, A. R., Piper, M., & Bonnycastle, M. (1987) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02097191 · Cited by 155
The NewClostridium difficile— What Does It Mean?
Bartlett, J. G., & Perl, T. M. (2005) · New England Journal of Medicine · doi:10.1056/nejme058221 · Cited by 153
Taylor, D. N., Bourgeois, A. L., Ericsson, C. D., Steffen, R. J., Jiang, Z., Halpern, J. L., Haake, R. J., DuPont, H. L., & _, _. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.1060 · Cited by 148
Evaluation of metronidazole toxicity: a prospective study.
Kapoor, K., Chandra, M., Nag, D., Paliwal, J., Gupta, R., & Saxena, R. C. (1999) · PubMed · Cited by 146
Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea
Juang, P., Skledar, S. J., Zgheib, N. K., Paterson, D. L., Vergis, E. N., Shannon, W. D., Ansani, N. T., & Branch, R. A. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.06.007 · Cited by 146
Rifaximin: A Novel Nonabsorbed Rifamycin for Gastrointestinal Disorders
Adachi, J. A., & DuPont, H. L. (2006) · Clinical Infectious Diseases · doi:10.1086/499950 · Cited by 146
Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A
Aboudola, S., Kotloff, K. L., Kyne, L., Warny, M., Kelly, E. C., Sougioultzis, S., Giannasca, P. J., Monath, T. P. C., & Kelly, C. P. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1608-1610.2003 · Cited by 138
Binding of Clostridium difficile Cytotoxin and Vancomycin by Anion-Exchange Resins
Taylor, N. S., & Bartlett, J. G. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/141.1.92 · Cited by 129
Role of surgery in antibiotic-induced pseudomembranous enterocolitis
Morris, J. B., Zollinger, R. M., & Stellato, T. A. (1990) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)81024-4 · Cited by 122
Wilcox, M. H., & Howe, R. A. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.673 · Cited by 122
Buggy, B. P., Fekety, R., & Silva, J. (1987) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198704000-00009 · Cited by 119
Lagrotteria, D. D., Holmes, S., Smieja, M., Smaill, F., & Lee, C. (2006) · Clinical Infectious Diseases · doi:10.1086/506354 · Cited by 118
Corthier, G., Muller, M. C., Wilkins, T. D., et al. (1991) · Infection and Immunity · doi:10.1128/iai.59.3.1192-1195.1991 · Cited by 111
In Vitro and In Vivo Activities of Nitazoxanide against Clostridium difficile
McVay, C. S., & Rolfe, R. D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2254-2258.2000 · Cited by 111
In Vitro Activity of OPT-80 against Clostridium difficile
Ackermann, G., Löffler, B., Adler, D., & Rodloff, A. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2280-2282.2004 · Cited by 110
GT160-246, a Toxin Binding Polymer for Treatment of Clostridium difficile Colitis
Kurtz, C. B., Cannon, E. P., Brezzani, A., Pitruzzello, M. C., Dinardo, C., Rinard, E., Acheson, D. W. K., Fitzpatrick, R., Kelly, P. J., Shackett, K., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2340-2347.2001 · Cited by 90
Rifalazil Treats and Prevents Relapse of Clostridium difficile -Associated Diarrhea in Hamsters
Anton, P. M., O’Brien, M. J., Kokkotou, E. G., Eisenstein, B. I., Michaelis, A. F., Rothstein, D., Paraschos, S., Kelly, C. P., & Pothoulakis, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3975-3979.2004 · Cited by 65
Owens, R. C. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.3.299 · Cited by 58
Intracolonic Vancomycin for Pseudomembranous Colitis
Pašić, M., Jost, R., Carrel, T. P., von Segesser, L., & Turina, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290819 · Cited by 57
Randomized controlled trial of colestipol in antibiotic-associated colitis
Mogg, G. A. G., GEORGE, R. H., Youngs, D. J., Johnson, M., Thompson, H., Burdon, D. W., & Keighley, M. R. B. (1982) · British journal of surgery · doi:10.1002/bjs.1800690306 · Cited by 56
Liacouras, C. A., & Piccoli, D. A. (1996) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199604000-00007 · Cited by 52
Hassett, J. M., Meyers, S., McFarland, L. V., & Mulligan, M. E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.supplement_2.s266 · Cited by 48
Moncino, M. D., & Falletta, J. M. (1992) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199211000-00015 · Cited by 48
"flora power"-fecal bacteria cure chronic C. difficile diarrhea
Borody, T. J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03277.x · Cited by 46
New Drugs for Clostridium difficile Infection
Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/506387 · Cited by 46
Update on pseudomembranous colitis.
Silva, J. J. (1989) · PubMed Central · Cited by 35
Recurrent Clostridium difficile-Associated Colitis Responding to Cholestyramine
Kunimoto, D., & Thomson, A. B. R. (2009) · Digestion · doi:10.1159/000199299 · Cited by 32
Pruksananonda, P., & Powell, K. R. (1989) · PubMed · Cited by 32
Sanchez, J. L., Gerding, D. N., Olson, M. M., et al. (1999) · Anaerobe · doi:10.1006/anae.1999.0268 · Cited by 22
Self-citationDrug Interaction between Simvastatin and Cholestyramine in Vitro and in Vivo.
Nakai, A., Nishikata, M., Matsuyama, K., et al. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1231 · Cited by 20
Update on Clostridium difficile
Thorpe, C. M., & Gorbach, S. L. (2006) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-006-0045-0 · Cited by 19
Cited by
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections
Löfmark, S., Edlund, C., & Nord, C. E. (2010) · Clinical Infectious Diseases · doi:10.1086/647939 · Cited by 656
Understanding the mechanisms of faecal microbiota transplantation
Khoruts, A., & Sadowsky, M. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.98 · Cited by 561
Can we identify patients at high risk of recurrent Clostridium difficile infection?
Kelly, C. P. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12046 · Cited by 396
Clostridium difficile infection: epidemiology, risk factors and management
Ananthakrishnan, A. N. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.190 · Cited by 352
Metadata
- Authors
- Gerding, D. N., Muto, C. A., & Owens, Jr.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-15
- Volume
- 46
- Issue
- s1
- Pages
- S32-S42
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2115024117
- Cited by
- 287
- References
- 90
- FWCI
- 27.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.